Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Effect of ATX-101 on QT/QTc Intervals
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 15, 2012
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess Injection Comfort of Two Formulations of ATX-101
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 22, 2011
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Novotech
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 24, 2021
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Novotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Allergan | Maryland Laser Skin & Vein Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 04, 2017
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Allergan | Maryland Laser Skin & Vein Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase IV
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 07, 2017
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase IV
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable